European Surgical Procedure Volumes 2016-2021 by Breast,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
29
European Surgical Procedure Volumes 2016-2021 by Breast, General, Gynecologic, Organ Transplant, Neurosurgical, Ophthalmalogic, and Urologic Surgeries

Dublin, June 13, 2018 (GLOBE NEWSWIRE) -- The "European Surgical Procedure Volumes: Breast, General, Gynecologic, Organ Transplant, Neurosurgical, Ophthalmalogic, and Urologic" report has been added to ResearchAndMarkets.com's offering.

This report presents procedure volumes forecasts for some of the most common surgical procedures performed in the five EU countries of France, Germany, Italy, Spain, and the UK (5EU). The forecast period covered by this report is for the years 2016 through 2021. This report also presents an overview of selected diseases/disorders, the prevailing surgical approaches and techniques, and the evolving procedural trends. Procedure volumes are provided for breast augmentation and reduction as well as general, gynecologic, organ transplant, neurosurgical, ophthalmologic, and urologic surgical procedures.

Key Topics Covered:

EXECUTIVE SUMMARY i. Methodology 1. EUROPEAN UNION HEALTHCARE OVERVIEW 1.1 GDP and healthcare spending 1.2 Healthcare financing 1.3 Healthcare economics 1.4 Healthcare facilities and personnel 1.5 Ambulatory surgery 1.6 Hospital length of stay 1.7 Unified healthcare 1.8 France, national healthcare profile 1.8.1 Healthcare organization and reform 1.8.2 Healthcare expenditure 1.8.3 Hospital services 1.9 Germany, national healthcare profile 1.9.1 Healthcare organization and reform 1.9.2 Hospital services 1.9.3 Funding 1.9.4 Electronic health records 1.10 Italy, national healthcare profile 1.10.1 Healthcare organization and reform 1.10.2 Funding 1.10.3 Hospital services 1.10.4 Electronic health records 1.11 Spain, national healthcare profile 1.11.1 Healthcare organization and reform 1.11.2 Hospital services 1.12 United Kingdom, national healthcare profile 1.12.1 Healthcare organization and reform 1.12.2 Funding 1.12.3 Healthcare expenditure 1.12.4 Hospital services 1.12.5 Effect of Brexit 1.13 Bibliography

  • Exhibit 1-1: Healthcare expenditures as a percentage of GDP, 2016
  • Exhibit 1-2: France, selected national healthcare statistics
  • Exhibit 1-3: Germany, selected national healthcare statistics
  • Exhibit 1-4: Italy, selected national healthcare statistics
  • Exhibit 1-5: Spain, selected national healthcare statistics
  • Exhibit 1-6: UK, selected national healthcare statistics

2. BREAST AUGMENTATION AND REDUCTION PROCEDURES 2.1 Breast augmentation 2.2 Breast reduction 2.3 Bibliography Exhibit 2-1: Breast augmentation, procedure volumes forecast, 2016-21 Exhibit 2-2: Breast reduction, procedure volumes forecast, 2016-21 3. GENERAL SURGICAL PROCEDURES 3.1 Weight loss procedures 3.2 Cholecystectomy 3.3 Colectomy 3.4 Esophagogastric fundoplasty 3.5 Liver biopsy 3.6 Bibliography

  • Exhibit 3-1: Prevalence of obesity, by classification, 2016-21
  • Exhibit 3-2: Bariatric surgery, procedure volumes forecast, 2016-21
  • Exhibit 3-3: Cholecystectomy, procedure volumes forecast, 2016-21
  • Exhibit 3-4: Colectomy, procedure volumes forecast, 2016-21
  • Exhibit 3-5: Esophagogastric fundoplasty, procedure volumes forecast, 2016-21
  • Exhibit 3-6: Liver biopsy, procedure volumes forecast, 2016-21

4. MAJOR ORGAN TRANSPLANTATION 4.1 Immunosuppressive strategies 4.2 Organ procurement and donor shortage 4.3 Organ transplantation, procedure volumes 4.4 Bibliography

  • Exhibit 4-1: Major organ transplantation, procedure volumes forecast, 2016-21

5. NEUROSURGICAL PROCEDURES 5.1 Selected disorders of the central and peripheral nervous systems 5.1.1 Hydrocephalus 5.1.2 Movement, seizure, and tremor disorders 5.1.3 Traumatic brain injury 5.2 The cerebrovascular system and selected disorders 5.2.1 Aneurysm 5.2.2 Arteriovenous malformation 5.2.3 Stroke 5.3 Bibliography

  • Exhibit 5-1: Ventriculostomy and ventricular shunting, procedure volumes forecast, 2016-21
  • Exhibit 5-2: Diagnosed prevalent cases of active epilepsy, five major EU markets, by country, 2016-21
  • Exhibit 5-3: Diagnosed prevalent cases of Parkinson's disease, five major EU markets, by country, 2016-21
  • Exhibit 5-4: Deep brain stimulation, procedure volumes forecast, 2016-21
  • Exhibit 5-5: Evacuation of subdural hematoma, procedure volumes forecast, 2016-21
  • Exhibit 5-6: Cerebral aneurysm clipping and coiling, procedure volumes forecast, 2016-21
  • Exhibit 5-7: Arteriovenous malformation embolization, procedure volumes forecast, 2016-21
  • Exhibit 5-8: Diagnosed incident cases of ischemic stroke, five major EU markets, by country, 2016-21
  • Exhibit 5-9: Carotid endarterectomy and carotid artery stenting, procedure volumes forecast, 2016-21

6. GYNECOLOGIC SURGICAL PROCEDURES 6.1 Dilation and curettage 6.2 Hysterectomy 6.3 Hysteroscopy 6.3.1 Endometrial ablation 6.3.2 Endometrial biopsy 6.4 Myomectomy 6.5 Oophorectomy 6.6 Salpingo-oophorectomy 6.7 Tubal ligation 6.8 Bibliography

  • Exhibit 6-1: Hysterectomy, procedure volumes forecast, 2016-21
  • Exhibit 6-2: Endometrial ablation, procedure volumes forecast, 2016-21
  • Exhibit 6-3: Endometrial biopsy, procedure volumes forecast, 2016-21
  • Exhibit 6-4: Myomectomy, procedure volumes forecast, 2016-21
  • Exhibit 6-5: Oophorectomy/salpingo-oophorectomy, procedure volumes forecast, 2016-21
  • Exhibit 6-6: Tubal ligation, procedure volumes forecast, 2016-21

7. OPHTHALMIC SURGICAL PROCEDURES 7.1 Age-related macular degeneration and diabetic retinopathy 7.2 Cataract surgery and intraocular implantation 7.3 Glaucoma 7.4 Refractive surgery 7.5 Vitrectomy 7.6 Bibliography

  • Exhibit 7-1: Prevalence of age-related macular degeneration, five major EU markets, 2016-21
  • Exhibit 7-2: Treatment for age-related macular degeneration and diabetic retinopathy, procedure volumes forecast, 2016-21
  • Exhibit 7-3: Cataract surgery and intraocular lens implantation, procedure volumes forecast, 2016-21
  • Exhibit 7-4: Glaucoma surgery, procedure volumes forecast, 2016-21
  • Exhibit 7-5: Refractive surgery, procedure volumes forecast, 2016-21
  • Exhibit 7-6: Vitrectomy, procedure volumes forecast, 2016-21

8. UROLOGIC SURGICAL PROCEDURES 8.1 Benign prostatic hyperplasia 8.1.1 Surgical approaches 8.1.2 Less invasive alternatives to surgery 8.1.3 Procedure volumes 8.2 Kidney stone obstruction 8.2.1 Procedure volumes 8.3 Female urinary incontinence 8.3.1 Procedure volumes 8.4 Bibliography

  • Exhibit 8-1: Benign prostatic hyperplasia treatment, procedure volumes forecast, 2016-21
  • Exhibit 8-2: Kidney stone removal, procedure volumes forecast, 2016-21
  • Exhibit 8-3: Female urinary incontinence treatment, procedure volumes forecast, 2016-21

For more information about this report visit https://www.researchandmarkets.com/research/9...gical?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Women's Health, Surgical Procedures , Neurology Devices

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Siili Solutions Unveils Exciting Employee Share Savings Plan

Updated Category News Views 120

Siili Solutions Introduces New Employee Share Savings Plan Siili Solutions Plc has recently taken a significant step to enhance employee engagement by approving a new plan period for its employee share savings plan, known as SiiliX Share. This announcement highlights the company’s commitment to fostering a culture of shared ownership and providing employees with an...

Continue Reading
Celldex Shares Exciting Insights at Major Investor Events

Updated Category News Views 118

Celldex's Participation in Key Investor Conferences Management from Celldex (NASDAQ:CLDX) recently announced their upcoming participation in several investor conferences aimed at providing insights into the company's innovative work in immunology. These events are pivotal platforms for investors and stakeholders to engage with industry leaders and gain insights into the...

Continue Reading
TSMC's Recent Export License Boosts Market Confidence and Operations

Updated Category News Views 110

TSMC Experiences Positive Market Sentiment Taiwan Semiconductor Manufacturing Company Limited (NASDAQ: TSM) shares saw an encouraging rise of 2.74% in premarket trading, reaching $312.25. This positive movement followed the recent granting of an annual export license by the U.S. Department of Commerce, which allows TSMC to import advanced chipmaking equipment to its...

Continue Reading
Fennec Pharmaceuticals Highlights Participation at Key Healthcare Conference

Updated Category News Views 1167

Fennec Pharmaceuticals Participating in Healthcare Conference In a significant announcement, Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a leader in specialty pharmaceutical innovations, has confirmed its participation in an engaging and insightful fireside chat as part of the Piper Sandler 37th Annual Healthcare Conference. This event is set to take place on...

Continue Reading
Transforming Housing in Canada with GroundBreak Ventures

Updated Category News Views 179

Introducing Future Housing Canada GroundBreak Ventures has launched an innovative national platform, Future Housing Canada, dedicated to modernizing housing delivery in Canada. This comprehensive web portal provides a clear guide for government officials, builders, developers, and industry stakeholders looking to tackle the pressing housing challenges faced across the...

Continue Reading